2m 2m 2m 2m 2m 2m 2m
INMUNE BIO-AI (INMB)
NASDAQ
$1.93$0.00 (0.00%)
Price as of Oct 02, 2026 5:39 PM EDT- $53.6MMarket Cap
- -9.81%1-Year Change
- BiotechnologyIndustry
INMUNE BIO-AI (INMB)
$1.93$0.00 (0.00%)
INMB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.93 | ||
Change | -$0.02 (-1.03%) | ||
Open | $1.96 | ||
High | $1.97 | ||
Low | $1.88 | ||
Previous Close | $1.95 | ||
Volume | 340,814 | ||
30-Day Average Volume | 340,768 | ||
1-Week Change | -3.50% | ||
1-Month Change | -13.84% | ||
1-Year Change | -9.81% | ||
3-Year Change | -71.49% | ||
5-Year Change | -90.53% | ||
Fundamentals | |||
Shares Outstanding | 27.8M | ||
Total Assets | $26.8M | ||
Market Cap | $53.6M | ||
Enterprise Value | $35.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$1.4M | ||
EBITDA | -$1.3M | ||
Net Working Capital | $17.9M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -39 | ||
PEG | -1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue